Xencor
Xencor is seeking a Scientist 2 to join the Antibody Discovery team, focusing on optimizing yeast-display discovery platforms and designing antibody libraries. The role involves conducting in vitro display campaigns to identify novel therapeutic hits and optimizing leads across various targets and diseases. Candidates will collaborate with diverse scientific groups to execute discovery screens, manage NGS data analysis, and report experimental results.
Headquarters
Pasadena, California, United States
Company Size
201-500 employees
Founded
1997
Xencor is a clinical-stage biopharmaceutical company that designs engineered proteins to create novel biologic medicines. Using proprietary protein-design platforms (including XmAb Fc engineering and cytokine/antibody engineering), Xencor builds next‑generation monoclonal antibodies, bispecifics and cytokine therapeutics with improved potency, half‑life and safety. The company advances an internal pipeline across oncology and immune‑mediated diseases while partnering with other biopharma organizations to discover and develop therapeutics. Xencor emphasizes rational protein design and translational science to deliver differentiated medicines to patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Xencor.
3% below the average for this role
Principal Scientist, Biotherapeutics Discovery, Antibody Generation
Digital Biology
Molecular Biologist (R6 – R7)
Eli Lilly and Company
Scientist
Digital Biology
Senior Scientist
AstraZeneca
Senior Scientist, Biologics Design and Display, Discovery Biologics
Merck & Co., Inc.
Principal Scientist, Biotherapeutics Discovery, Antibody Generation
Digital Biology